,i #aaith ,,congress #ast ,session ,h4 ,r4 #agej ,,in ,,the ,,house ,,of ,,representatives ,february #bg1 #bjbe,ms4 ,strickland introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,ways and ,means1 and ,natural ,resources1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,public ,health ,service ,act to provide for greater investments in research on rare diseases and conditions disproportionately affecting minority populations1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,health ,equity and ,rare ,disease ,act of #bjbe or the ,,heard ,act of #bjbe4 #b4 ,,nih expansion1 intensification1 and coordination of research on rare diseases health equity ,part ,b of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhd et seq47 is amended by adding at the end the following3 #dji,k4 ,rare diseases health equity 7a7 ,expansion1 intensification1 and coordination of activities 7#a7 ,in general ,the ,director of ,,nih shall expand1 intensify1 and coordinate research and other activities of the ,national ,institutes of ,health with respect to rare diseases health equity4 7#b7 ,allocations by ,director of ,,nih ,with respect to amounts appropriated to carry out this section for a fiscal year1 the ,director of ,,nih shall allocate the amounts among the national research institutes that are carrying out paragraph 7#a74 7b7 ,coordinating ,committee 7#a7 ,in general ,the ,secretary shall maintain a coordinating committee with respect to rare diseases health equity 7referred to in this section as the ,coordinating ,committee7 to coordinate activities across the ,national ,institutes and with other ,federal health programs and activities relating to rare diseases health equity4 7#b7 ,composition ,the ,coordinating ,committee shall be composed of-- 7,a7 the directors 7or their designees7 of each of the national research institutes involved in research with respect to rare diseases and minority health or health equity2 and 7,b7 representatives of all other ,federal departments and agencies whose programs involve health functions or responsibilities relevant to such rare diseases1 including the ,centers for ,disease ,control and ,prevention and the ,food and ,drug ,administration4 7#c7 ,chair 7,a7 ,in general ,with respect to rare diseases health equity1 the ,chair of the ,coordinating ,committee shall serve as the principal advisor to the ,secretary1 the ,assistant ,secretary for ,health1 and the ,director of ,,nih1 and shall provide advice to the ,director of the ,centers for ,disease ,control and ,prevention1 the ,commissioner of ,food and ,drugs1 and other relevant agencies4 7,b7 ,director of ,,nih ,the ,chair of the ,coordinating ,committee shall be directly responsible to the ,director of ,,nih4 7c7 ,plan for ,,nih ,activities 7#a7 ,in general ,not later than #a year after the date of the enactment of this section1 the ,coordinating ,committee shall develop a plan for conducting and supporting research and education on rare diseases health equity1 and rare diseases or conditions in minority populations1 through the national research institutes4 ,the ,coordinating ,committee shall periodically review and revise the plan4 ,the plan shall-- 7,a7 provide for a broad range of research and education activities relating to biomedical1 psychosocial1 and rehabilitative issues1 including studies of the disproportionate impact of such diseases or conditions on minority populations2 7,b7 identify priorities among the programs and activities of the ,national ,institutes of ,health regarding such diseases or conditions2 and 7,c7 reflect input from a broad range of scientists1 patients1 and advocacy groups4 7#b7 ,certain elements of plan ,the plan under paragraph 7#a7 shall1 with respect to rare diseases or conditions in minority populations1 provide for the following as appropriate3 7,a7 ,research to determine the reasons underlying the incidence and prevalence of the diseases or conditions1 including among subpopulations4 7,b7 ,basic research concerning the etiology and causes of the diseases or conditions4 7,c7 ,epidemiological studies to address the frequency and natural history of the diseases or conditions1 including any differences among the sexes and among racial and ethnic groups4 7,d7 ,the development of improved screening techniques4 7,e7 ,clinical research for the development and evaluation of new treatments1 including new biological agents4 7,f7 ,information and education programs for health care professionals and the public4 7#c7 ,implementation of plan ,the ,director of ,,nih shall ensure that programs and activities of the ,national ,institutes of ,health regarding rare diseases or conditions in minority populations are implemented in accordance with the plan under paragraph 7#a74 7d7 ,definitions ,in this section3 7#a7 ,the term minority has the meaning given such term in section #dfdz-#c4 7#b7 ,the term rare disease or condition has the meaning given such term in section #ebf of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bb74 4 #c4 ,collaborative comprehensive plan to address rare diseases and conditions in minority populations ,subpart #bj of part ,c of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhet et seq47 is amended by adding at the end the following3 #dfdz-#g4 ,collaborative comprehensive plan to address rare diseases and conditions in minority populations ,not later than #ahj days after the date of enactment of this section1 the ,director of ,,nih1 the ,director of the ,institute1 the ,director of the ,national ,center for ,advancing ,translational ,sciences1 the ,director of the ,national ,heart1 ,lung1 and ,blood ,institute1 and the directors of the other agencies of the ,national ,institutes of ,health in collaboration 7and in consultation with the advisory council for the ,institute7 shall-- 7#a7 develop a comprehensive ,federal plan to address rare diseases and conditions in minority populations 7as those terms are defined in section #dji,k71 including a strategy to increase diversity in genetic programs at the program for ,therapeutics for ,rare and ,neglected ,diseases at the ,national ,institutes of ,health2 7#b7 conduct or support through grants or cooperative agreements basic1 clinical1 and translational research on rare diseases and conditions in minority populations1 including research on-- 7,a7 early detection1 diagnosis1 and treatment of such diseases and conditions in such populations2 and 7,b7 improving the quality of life for individuals with rare diseases or conditions and their families2 7#c7 conduct or support clinical training programs for physicians and other health care practitioners with respect to detecting1 diagnosing1 and treating such diseases and conditions in such populations2 and 7#d7 develop guidance for increasing participation of health professionals who are members of minority groups 7as defined in section #dfdz-#c7 in research conducted or supported by the ,national ,institutes of ,health on such diseases and conditions in such populations4 4 #d4 ,grants to collect and analyze data on rare diseases and conditions in minority populations ,section #agjg7;b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjju-#f7;b77 is amended by adding at the end the following3 7#aa7 ,in coordination with the ,director of the ,centers for ,disease ,control and ,prevention1 award grants to public and private nonprofit entities to-- 7,a7 collect1 analyze1 and report data on rare diseases and conditions in minority populations1 including on epidemiological data with respect to incidence of such diseases and conditions in such populations2 7,b7 conduct outreach and engagement activities with the minority populations impacted by such rare diseases and conditions by-- 7i7 improving health literacy with respect to rare diseases and conditions2 7ii7 disseminating information on health and community services related to rare diseases and conditions2 and 7iii7 providing information regarding the maintenance of rare diseases and conditions4 7#ab7 ,submit to ,congress1 on a biannual basis 7beginning not later than #b years after the date of the enactment of the ,,heard ,act of #bjbe71 a report describing the activities carried out pursuant to paragraph 7#aa74 4 #e4 ,physician training programs with respect to rare diseases ,subpart ,,ii of part ,c of title ,,vii of the ,public ,health ,service ,act is amended by adding at the end the following3 #gdi;,c4 ,physician training programs with respect to rare diseases 7a7 ,in general ,the ,secretary shall establish a program to award grants to accredited schools of allopathic medicine1 osteopathic medicine1 and nursing1 and other health professional training programs for the training of health care professionals-- 7#a7 to improve the provision of care to individuals who have rare diseases or conditions 7as defined in section #ebf of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bb772 7#b7 to improve the provision of care to such individuals via telehealth2 and 7#c7 to conduct research relevant to rare diseases and conditions4 7b7 ,eligibility ,to be eligible for a grant under subsection 7a71 an entity described in such subsection shall submit to the ,secretary an application at such time1 in such manner1 and containing such information as the ,secretary may require4 7c7 ,reporting requirements 7#a7 ,periodic reports ,each entity awarded a grant under this section shall periodically submit to the ,secretary a report on the status of activities conducted using the grant1 including a description of the impact of such training on patient outcomes1 as applicable4 7#b7 ,report to ,congress ,not later than #b years after the date of enactment of this section1 the ,secretary shall submit a report to ,congress on the activities conducted using grants under subsection 7a7 and any best practices identified and disseminated under subsection 7d74 7d7 ,best practices ,the ,secretary may identify and disseminate best practices for the training described in subsection 7a74 #gdi;,d4 ,health professionals education on rare diseases and conditions in minority populations 7a7 ,in general ,the ,secretary may award grants1 cooperative agreements1 and contracts to accredited schools of medicine and nursing1 and other health professional training programs1 for the development and implementation of programs to provide education and training to health care professionals on the causes and effects of rare diseases and conditions in minority populations4 7b7 ,definitions ,in this section3 7#a7 ,the term minority has the meaning given such term in section #dfdz-#c4 7#b7 ,the term rare disease or condition has the meaning given such term in section #ebf of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bb74 #gdi;,e4 ,mentoring program for health care professionals seeking to work in rare diseases and conditions ,the ,secretary1 acting through the ,administrator of the ,health ,resources and ,services ,administration1 may award grants1 contracts1 or cooperative agreements to public and nonprofit private entities 7including ,tribal entities7 for the establishment of a mentoring program for health care professionals seeking to treat patients with rare diseases and conditions4 #gdi;,f4 ,scholarship and loan repayment program for physicians and genetic counselors serving populations with rare diseases and conditions 7a7 ,loan repayment program 7#a7 ,in general ,the ,secretary shall establish a program of entering into contracts with eligible individuals under which the individuals agree to serve as health care professionals serving populations with rare diseases or conditions in consideration of the ,federal ,government agreeing to pay1 for each year of such service1 up to #ej1jjj 7plus an amount determined by the ,secretary on an annual basis to reflect inflation7 of the principal and interest of the educational loans of such individuals4 7#b7 ,determination of amount ,in making a determination of the amount to pay for a year of such service by an individual1 the ,secretary shall consider the extent to which each such determination-- 7,a7 affects the ability of the ,secretary to maximize the number of contracts that can be provided under the program from the amounts appropriated for such contracts2 7,b7 provides an incentive to serve as health care professionals serving populations with rare diseases or conditions2 and 7,c7 provides an incentive with respect to the health professional involved to remain serving populations with rare diseases or conditions1 including after the completion of the period of obligated service under the program4 7#c7 ,eligible individuals ,in this subsection1 the term eligible individual means an individual who is enrolled or accepted for enrollment as a full-time or part-time student in a school of medicine4 7#d7 ,applicability of certain provisions ,with respect to the ,national ,health ,service ,corps ,loan ,repayment ,program established in subpart ,,iii of part ,d of title ,,iii of this ,act1 the provisions of such subpart shall1 except as inconsistent with paragraph 7#a71 apply to the program established in this section in the same manner and to the same extent as such provisions apply to the ,national ,health ,service ,corps ,loan ,repayment ,program4 7b7 ,scholarship program 7#a7 ,in general ,the ,secretary shall carry out a program of entering into contracts with eligible individuals under which each such individual agrees to serve1 for a period of not less than #e years1 as a health care professional primarily serving populations with rare diseases or conditions1 in consideration of the ,federal ,government agreeing to provide to the individual a scholarship for attendance at a school of medicine4 7#b7 ,eligible individuals ,in this subsection1 the term eligible individual means an individual who is enrolled or accepted for enrollment as a full-time or part-time student in a school of medicine4 7#c7 ,applicability of certain provisions ,the provisions of subpart ,,iii of part ,d of title ,,iii shall1 except as inconsistent with this section1 apply to the program established in paragraph 7#a7 in the same manner and to the same extent as such provisions apply to the ,national ,health ,service ,corps ,scholarship ,program established in such subpart4 4 #f4 ,increasing minority representation in research on rare diseases and conditions ,part ,g of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhh et seq47 is amended by adding at the end the following3 #dhg;,e4 ,increasing minority representation in research on rare diseases and conditions 7a7 ,grant program ,in carrying out section #dhg1 the ,secretary may award grants to eligible entities involved in research on rare diseases and minority health to establish programs to increase the recruitment and retention of members of minority groups to conduct research in matters relating to the cause1 diagnosis1 prevention1 and treatment of rare diseases or conditions1 including by expanding the number of internships and mentoring opportunities4 7b7 ,eligible entities ,in subsection 7a71 the term eligible entities means accredited schools of allopathic medicine1 osteopathic medicine1 and nursing1 and other health professional training programs4 4 #g4 ,report to ,congress on ,federal efforts on rare diseases and conditions in minority populations ,not later than #b years after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,director of the ,national ,institutes of ,health and in consultation with the ,director of the ,centers for ,disease ,control and ,prevention1 shall submit to ,congress-- 7#a7 a report on research and public health activities carried out by the ,federal ,government with respect to rare diseases or conditions in minority populations 7as those terms are defined in section #dji,k of the ,public ,health ,service ,act1 as added by section #b of this ,act72 7#b7 a comprehensive list of known rare diseases and conditions that impact minority populations heavily or disproportionately2 and 7#c7 an analysis of data gaps with respect to rare diseases and conditions and the effect of such diseases and conditions on minority populations4 #h4 ,research and awareness campaigns with respect to rare diseases and conditions in minority populations ,part ,b of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdc et seq47 is amended by inserting after section #cag,v 7#db ,u4,s4,c4 #bdg;b-#bd7 the following3 #cag,w4 ,research and awareness campaigns with respect to rare diseases and conditions in minority populations 7a7 ,research ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 shall conduct or support research and carry out public health awareness campaigns with respect to rare diseases and conditions in minority populations 7as defined in section #dji,k74 7b7 ,awareness campaign ,the ,secretary shall1 directly or through grants or contracts1 establish a public education program in cooperation with existing national public awareness campaigns to increase awareness about rare diseases and conditions in minority populations through culturally and linguistically appropriate information campaigns about prevention and management of rare diseases and conditions4 4 #i4 ,,fda survey and report on clinical trial diversity ,not later than #b years after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall-- 7#a7 conduct a survey of policies and programs of the ,food and ,drug ,administration to support an increase the availability of clinical trial data on minority populations1 with an emphasis on minority populations with rare diseases and conditions2 and 7#b7 submit to ,congress a report containing-- 7,a7 the findings of such survey2 7,b7 the ,secretary's recommendations for statutory or regulatory changes to increase the availability of such data2 7,c7 the ,secretary's recommendations for strategies to encourage drug manufacturers to address racial equity and inclusion in research and development of treatments of rare diseases or conditions that disproportionately impact minority populations2 and 7,d7 the ,secretary's recommendations for strategies to address research and development of treatments of rare diseases or conditions that disproportionately impact minority populations4 #aj4 ,tribal epidemiology center grant program ,title ,,ii of the ,indian ,health ,care ,improvement ,act 7#be ,u4,s4,c4 #afba et seq47 is amended by adding at the end the following3 #bbg4 ,tribal epidemiology center grant program 7a7 ,in general ,the ,secretary1 acting through the ,service1 shall award grants to ,tribal ,epidemiology ,centers and ,tribal and ,urban ,indian ,health ,centers to support clinically and culturally appropriate research and other activities with respect to rare diseases and conditions in ,native ,american or ,tribal communities4 7b7 ,permissible activities ,the activities funded through a grant under subsection 7a7 may include coordination of data collection on the prevention1 diagnosis1 treatment1 and care of rare diseases and conditions by health care professionals serving ,american ,indian and ,alaska ,native populations4 4 #aa4 ,medicare review and report ,not later than #ahj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,service shall conduct a review of and submit to ,congress a report on the following3 7#a7 ,regulatory barriers under the ,medicare program under title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #acie et seq47 that inhibit access to the treatment of rare diseases for ,medicare beneficiaries of color1 including barriers that inhibit health care providers from improving care related to such diseases for such beneficiaries4 7#b7 ,requirements relating to the furnishing of telehealth services under such title insofar as such services relate to the treatment of rare diseases4 ,such report shall include any recommendations determined appropriate by the ,secretary based on such review4